regulatory T cell therapy Treg
Orca Bio’s Tregzi Is the First Regulatory T Cell Therapy Ever Approved
The FDA approved Orca Bio’s Tregzi on June 30, making it the first regulatory T cell-based immunotherapy to receive clearance in the agency’s history. The next morning it expanded Casgevy’s label to children as young as two, placing a potentially curative CRISPR gene therapy within reach of approximately 5,500 additional American children with sickle cell…
